Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

PT-141 (Bremelanotide)vsTB-500

The first FDA-approved peptide that works through your brain to reignite sexual desire—think of it as flipping the 'on' switch for arousal rather than just boosting blood flow like traditional ED meds.

A powerful fragment of thymosin beta-4 that acts like your body's repair signal—speeding up healing of muscles, tendons, and tissues by promoting cell migration and new blood vessel growth right where you need it most.

Sexual HealthHealing & Recovery

At a Glance

Quick
comparison

Dose Range

PT-141 (Bremelanotide)

1.75–2 mg

TB-500

2–5 mg

Frequency

PT-141 (Bremelanotide)

As needed

TB-500

Twice weekly

Administration

PT-141 (Bremelanotide)

Subcutaneous injection

TB-500

Subcutaneous injection

Cycle Length

PT-141 (Bremelanotide)

Ongoing/indefinite

TB-500

4-6 weeks

Onset Speed

PT-141 (Bremelanotide)

Rapid (hours to days)

TB-500

Moderate (1-2 weeks)

Evidence Level

PT-141 (Bremelanotide)

Strong human trials (Phase 3 or FDA approved)

TB-500

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

PT-141 (Bremelanotide)
TB-500

Sexual Desire

PT-141 (Bremelanotide)92%
TB-5000%

On-Demand Use

PT-141 (Bremelanotide)95%
TB-5000%

Clinical Evidence

PT-141 (Bremelanotide)98%
TB-5000%

Healing Speed

PT-141 (Bremelanotide)0%
TB-50095%

Tissue Repair

PT-141 (Bremelanotide)0%
TB-50093%

Anti-Scarring

PT-141 (Bremelanotide)0%
TB-50088%

Technical Data

Compound
specifications

PT-141 (Bremelanotide)

Molecular Formula

C50H68N14O10

Molecular Weight

1025.2 g/mol

Half-Life

2.7 hours

Bioavailability

~100% (subcutaneous injection)

CAS Number

189691-06-3

TB-500

Molecular Formula

C38H68N10O14

Molecular Weight

889.01 g/mol

Half-Life

2-3 days (systemic)

Bioavailability

High via subcutaneous injection (~100%)

CAS Number

885340-08-9

Protocols

Dosing
tiers

PT-141 (Bremelanotide)

starting

1 mg

As needed (45 min before activity)

Trial period

Starting low helps you gauge your response to nausea, which is the most common side effect. If you tolerate 1mg well, you can increase to the standard dose. Never take more than one dose in 24 hours.

standard

1.75 mg

As needed (45 min before activity)

Ongoing as needed

This is the FDA-approved dose for treating HSDD in women. Clinical trials showed this dose provides the best balance of effectiveness and tolerability. Don't exceed 8 doses per month.

advanced

2 mg

As needed (45 min before activity)

Ongoing as needed

Some research protocols and clinicians use up to 2mg, though 1.75mg is the FDA-approved dose. Higher doses increase the risk of nausea without necessarily improving effectiveness. Stay within the 8 doses per month limit.

TB-500

starting

2-2.5 mg

Twice weekly

4-6 weeks

Start here to assess your tolerance and response. Many people see good results at this dose. Split your weekly dose into two injections spaced 3-4 days apart (like Monday and Thursday).

standard

4-5 mg

Twice weekly (split into 2-2.5 mg doses)

4-6 weeks

The most commonly used protocol for moderate injuries. Your total weekly dose is 4-5 mg, split into two injections. This is the sweet spot where most users see significant healing benefits.

advanced

5-10 mg

Twice weekly (2.5-5 mg per injection)

4-8 weeks

Higher doses for severe or stubborn injuries. Some protocols use a loading phase of higher doses for 1-2 weeks, then drop to maintenance. Work with a provider for doses above 5 mg weekly.

Applications

Best
suited for

PT-141 (Bremelanotide)

Women with Low Sexual Desire (HSDD)

PT-141 is FDA-approved specifically for premenopausal women with acquired, generalized hypoactive sexual desire disorder—when you used to have normal desire but it's faded, and it's causing real distress in your life. It's the only approved treatment that works through brain pathways rather than hormones.

Men Who Don't Respond to Viagra-Type Medications

While not FDA-approved for men, clinical research shows PT-141 may help men with erectile dysfunction who don't respond to PDE5 inhibitors like Viagra or Cialis. Because it works through the brain rather than blood vessels, it offers a completely different approach.

Those Wanting On-Demand Treatment

Unlike daily medications like flibanserin (Addyi), PT-141 is used only when you want it—take it 45 minutes before intimacy. This gives you control over timing without committing to daily pills.

People Seeking to Address the 'Wanting' Part of Intimacy

Many sexual health treatments focus on the physical mechanics (blood flow, lubrication). PT-141 is unique because it targets desire itself—the psychological 'wanting' that initiates intimacy. It works on your brain's arousal circuits.

TB-500

Athletes Recovering from Muscle Injuries

If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal.

Tendon and Ligament Problems

Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues.

Post-Surgical Recovery

After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline.

Chronic Inflammation and Slow Healers

Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most.

Safety Profile

Side
effects

PT-141 (Bremelanotide)

Common

  • Nausea
  • Facial flushing
  • Headache
  • Injection site reactions

Uncommon

  • Skin darkening (hyperpigmentation)

Serious

  • Blood pressure increase

TB-500

Common

  • Injection site redness
  • Mild fatigue or lethargy
  • Mild headache
  • Slight flushing

Uncommon

  • Head rush or lightheadedness
  • Temporary nausea

Serious

  • Allergic reaction

Research Status

Safety
& evidence

PT-141 (Bremelanotide)

Evidence Level

Strong human trials (Phase 3 or FDA approved)

FDA Status

FDA approved for this use

Safety Overview

PT-141 has undergone rigorous FDA review and was approved in 2019 based on two large Phase 3 clinical trials involving over 1,200 women. The most common side effect is nausea (affecting about 40% of users), which typically decreases with repeated use. The drug causes transient increases in blood pressure (average 2-3 mmHg) and slight decreases in heart rate, which is why it's contraindicated in uncontrolled hypertension. Long-term safety data from the 52-week extension study showed no new safety concerns.

Contraindications

  • xUncontrolled high blood pressure
  • xCardiovascular disease
  • xHistory of heart attack or stroke
  • xPregnancy or planning pregnancy
  • xCurrently breastfeeding

TB-500

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans.

Contraindications

  • xPregnancy or planning to become pregnant
  • xCurrently breastfeeding
  • xActive cancer or history of cancer
  • xKnown allergy to peptide components
  • xChildren and adolescents

Decision Guide

Which is
right for you?

Choose PT-141 (Bremelanotide) if...

  • Restoring sexual desire
  • Treating hypoactive sexual desire disorder (HSDD)
  • Enhancing arousal response
  • Supporting intimacy when desire is low

Choose TB-500 if...

  • Accelerating injury recovery
  • Tendon and ligament healing
  • Reducing chronic inflammation
  • Post-surgical recovery support
Peptide ProPT-141 (Bremelanotide) vs TB-500 — Peptide Comparison | Peptide Initiative